A detailed history of Northern Trust Corp transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,180,016 shares of RVMD stock, worth $51.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,180,016
Previous 1,214,271 2.82%
Holding current value
$51.8 Million
Previous $39.1 Million 17.02%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$30.14 - $40.68 $1.03 Million - $1.39 Million
-34,255 Reduced 2.82%
1,180,016 $45.8 Million
Q1 2024

May 14, 2024

SELL
$26.56 - $33.55 $1.5 Million - $1.9 Million
-56,524 Reduced 4.45%
1,214,271 $39.1 Million
Q4 2023

Feb 13, 2024

BUY
$18.35 - $34.12 $6.2 Million - $11.5 Million
337,670 Added 36.19%
1,270,795 $36.4 Million
Q3 2023

Nov 13, 2023

BUY
$25.17 - $35.05 $388,423 - $540,891
15,432 Added 1.68%
933,125 $25.8 Million
Q2 2023

Aug 11, 2023

BUY
$20.28 - $27.0 $2.68 Million - $3.57 Million
132,136 Added 16.82%
917,693 $24.5 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $2.28 Million - $3.31 Million
109,885 Added 16.26%
785,557 $17 Million
Q4 2022

Feb 13, 2023

BUY
$17.68 - $25.53 $330,828 - $477,717
18,712 Added 2.85%
675,672 $16.1 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $310,718 - $462,696
17,796 Added 2.78%
656,960 $13 Million
Q2 2022

Aug 12, 2022

BUY
$14.54 - $27.17 $135,440 - $253,088
9,315 Added 1.48%
639,164 $12.5 Million
Q1 2022

May 13, 2022

BUY
$17.31 - $26.4 $1.19 Million - $1.82 Million
68,794 Added 12.26%
629,849 $16.1 Million
Q4 2021

Feb 08, 2022

BUY
$24.35 - $33.7 $33,773 - $46,741
1,387 Added 0.25%
561,055 $14.1 Million
Q3 2021

Nov 15, 2021

SELL
$23.95 - $33.41 $149,615 - $208,712
-6,247 Reduced 1.1%
559,668 $15.4 Million
Q2 2021

Aug 13, 2021

BUY
$29.0 - $47.44 $2.73 Million - $4.46 Million
94,062 Added 19.93%
565,915 $18 Million
Q1 2021

May 12, 2021

BUY
$37.21 - $54.43 $1.03 Million - $1.5 Million
27,583 Added 6.21%
471,853 $21.6 Million
Q4 2020

Feb 11, 2021

SELL
$30.19 - $45.49 $226,364 - $341,084
-7,498 Reduced 1.66%
444,270 $17.6 Million
Q3 2020

Nov 16, 2020

BUY
$22.61 - $34.8 $5.77 Million - $8.88 Million
255,285 Added 129.93%
451,768 $15.7 Million
Q2 2020

Aug 14, 2020

BUY
$19.65 - $39.34 $905,688 - $1.81 Million
46,091 Added 30.65%
196,483 $6.2 Million
Q1 2020

May 14, 2020

BUY
$20.0 - $34.08 $3.01 Million - $5.13 Million
150,392 New
150,392 $3.3 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.85B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.